Astorg Partners
Astorg inks first US deal with Anaqua
GP uses Astorg VII, closed last month on €4bn, to acquire a stake in software developer Anaqua
GP Profile: Astorg
Managing partner Thierry Timsit discusses investment strategy, competition, ESG and political instability
Astorg holds €4bn final close for seventh fund
Three months after launch, Astorg's seventh fund exceeds €3.2bn target and nears hard-cap
Astorg's M7 buys division of Liberty Global's TV operations
Luxembourg-based M7 Group bolts on eastern European TV operations of Liberty Global
French PE investment in aerospace soars to new heights
Asset class is fuelling growth in the industry, with aggregate value in France picking up pace in recent years
Astorg buys Aries Alliance in SBO
Phoenix, CM-CIC Investissement, BNP Paribas Développement and Ace Management exit the business
Montagu sells Nemera to Astorg in €1bn deal
Nemera is valued at more than €1bn and will post a 2018 EBITDA of €70m, say reports
Partners Group buys Megadyne in SBO
Company's founders, the Tadolini family, reinvested in the business alongside Partners Group
Astorg buys IGM Resins from Arsenal Capital Partners
French GP acquires the Dutch ultraviolet curable materials manufacturer in a secondary buyout
Astorg to sell Metrologic to trade
French 3D measurement specialist Metrologic to be sold to Swedish Sandvik in €360m deal
Cathay and OrbiMed divest Echosens to Astorg
Deal is the first exit for Cathay's 2014-vintage €500m Sino-European MidCap fund
Abénex, Astorg sell Onduline to Naxicap
Company's management team, led by Richard Seguin, will retain a minority stake alongside Naxicap
Astorg's Parkeon to bolt on Cale
French parking services provider Parkeon starts talks to acquire Sweden-based Cale
Astorg, Montagu fully exit Sebia
CVC Strategic Opportunities and the Bettencourt-Meyers family office join CDPQ as shareholders
Astorg, Montagu partially exit Sebia to CDPQ
Astorg and Montagu acquired the healthcare company from Cinven in 2014
Astorg acquires Surfaces Technological Abrasives
Previous investor Xenon Private Equity acquired its majority stake in the company in 2015
Deal in Focus: Epiris sells Audiotonix to Astorg
Sale of the audio mixing console business will generate a return of 4.8x and IRR of 51% for the vendor
PAI-backed Ethypharm acquires Martindale Pharma
New combined entity will generate revenues in excess of €300m
Deal in Focus: Astorg sells Kerneos to Imerys for €880m
Sale of the specialised chemicals company follows a three-year holding period in which the group invested in new ventures and made bolt-ons
Astorg sells Kerneos to Imerys for €880m
Entreprise value represents an 8.8x EBITDA multiple and is expected to close in summer 2017
Astorg sells Metalor to Japanese buyer
Exit comes two weeks after Astorg closed its sixth buyout fund on €2.1bn
Astorg closes Astorg VI fund on €2.1bn extended hard-cap
GP's fourth fund closes above original €1.5bn target and €2bn hard-cap
Deal in Focus: Astorg sells Ethypharm after nine-year holding
Resisting regular suitors, the GP's nine-year tenure of the pharmaceutical company allowed it to fully implement a long-term acquisitive strategy
PAI in €725m deal to acquire Ethypharm from Astorg
Deal comes nine years after Astorg acquired a 60% stake in the company via the Astorg IV fund